• Avalon GloboCare received Nasdaq notice dated April 15, 2026 for noncompliance with minimum bid price rule requiring at least USD 1 per share.
• Deficiency was triggered by closing bid prices below USD 1 for 30 consecutive business days from March 1, 2026 to April 14, 2026.
• Nasdaq set deadline of Oct. 12, 2026 to regain compliance via a closing bid price of at least USD 1 for 10 consecutive business days.
• Failure to meet deadline could lead to delisting notice, subject to eligibility for an additional 180-day cure period.
• Company is weighing actions to restore compliance, including a potential reverse stock split.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalon Globocare Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-045160), on April 17, 2026, and is solely responsible for the information contained therein.